Christensen, B <br/><br/>
Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' reply.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  05 2018 
 - 1423-1424 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/apt.14638  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized<br/>Cholangitis, Sclerosing<br/>Humans<br/>Inflammatory Bowel Diseases<br/>Liver Diseases